These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta. Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420 [TBL] [Abstract][Full Text] [Related]
10. The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. Burdick AD; Kim DJ; Peraza MA; Gonzalez FJ; Peters JM Cell Signal; 2006 Jan; 18(1):9-20. PubMed ID: 16109478 [TBL] [Abstract][Full Text] [Related]
11. PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine. Reed KR; Sansom OJ; Hayes AJ; Gescher AJ; Winton DJ; Peters JM; Clarke AR Oncogene; 2004 Nov; 23(55):8992-6. PubMed ID: 15480419 [TBL] [Abstract][Full Text] [Related]
12. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist. Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832 [TBL] [Abstract][Full Text] [Related]
13. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts. Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta. Kim HJ; Ham SA; Kim SU; Hwang JY; Kim JH; Chang KC; Yabe-Nishimura C; Kim JH; Seo HG Circ Res; 2008 Feb; 102(2):193-200. PubMed ID: 18007025 [TBL] [Abstract][Full Text] [Related]
15. PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells. Ritzenthaler JD; Roman J; Han S Methods Mol Biol; 2009; 512():309-23. PubMed ID: 19347285 [TBL] [Abstract][Full Text] [Related]
16. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy. Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663 [TBL] [Abstract][Full Text] [Related]
17. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161 [TBL] [Abstract][Full Text] [Related]
18. The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration. Tan NS; Icre G; Montagner A; Bordier-ten-Heggeler B; Wahli W; Michalik L Mol Cell Biol; 2007 Oct; 27(20):7161-75. PubMed ID: 17682064 [TBL] [Abstract][Full Text] [Related]
19. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome. Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor delta agonists attenuated the C-reactive protein-induced pro-inflammation in cardiomyocytes and H9c2 cardiomyoblasts. Liang YJ; Chen CY; Juang SJ; Lai LP; Shyu KG; Wang BW; Liu SY; Leu JG Eur J Pharmacol; 2010 Sep; 643(1):84-92. PubMed ID: 20599914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]